Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;32(5):673-674.
doi: 10.1016/j.annonc.2021.01.066. Epub 2021 Jan 30.

Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey

J Barrière  1 , J Gal  2 , B Hoch  3 , O Cassuto  4 , A Leysalle  5 , E Chamorey  2 , D Borchiellini  6
Affiliations

Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey

J Barrière et al. Ann Oncol. 2021 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors have declared no conflicts of interest.

Figures

Figure 1
Figure 1
Predictors of SARS-CoV-2 vaccination acceptance. Prior flu vac.: prior seasonal influenza vaccination.
See this image and copyright information in PMC

References

    1. Anderson E.J., Rouphael N.G., Widge A.T. Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults. N Engl J Med. 2020;383(25):2427–2438. - PMC - PubMed
    1. Lee L.Y.W., Cazier J.B., Starkey T. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncol. 2020;21(10):1309–1316. - PMC - PubMed
    1. Meerveld-Eggink A., de Weerdt O., van der Velden A.M.T. Response to influenza virus vaccination during chemotherapy in patients with breast cancer. Ann Oncol. 2011;22(9):2031–2035. - PubMed
    1. Yri O.E., Torfoss D., Hungnes O. Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment. Blood. 2011;118(26):6769–6771. - PubMed
    1. Rousseau B., Loulergue P., Mir O. Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study. Ann Oncol. 2012;23(2):450–457. - PubMed

Substances